Immunophenotypic and gene expression analysis of monoclonal B-cell lymphocytosis shows biologic characteristics associated with good prognosis CLL

M. C. Lanasa, S. D. Allgood, S. L. Slager, S. S. Dave, C. Love, G. E. Marti, N. E. Kay, C. A. Hanson, K. G. Rabe, S. J. Achenbach, L. R. Goldin, N. J. Camp, B. K. Goodman, C. M. Vachon, L. G. Spector, L. Z. Rassenti, J. F. Leis, J. P. Gockerman, S. S. Strom, T. G. CallM. Glenn, J. R. Cerhan, M. C. Levesque, J. B. Weinberg, N. E. Caporaso

Research output: Contribution to journalArticlepeer-review

34 Scopus citations


Monoclonal B-cell lymphocytosis (MBL) is a hematologic condition wherein small B-cell clones can be detected in the blood of asymptomatic individuals. Most MBL have an immunophenotype similar to chronic lymphocytic leukemia (CLL), and CLL-like MBL is a precursor to CLL. We used flow cytometry to identify MBL from unaffected members of CLL kindreds. We identified 101 MBL cases from 622 study subjects; of these, 82 individuals with MBL were further characterized. In all, 91 unique MBL clones were detected: 73 CLL-like MBL (CD5+ CD20dim sIgdim), 11 atypical MBL (CD5+ CD20+ sIg+) and 7 CD5neg MBL (CD5neg CD20+ sIgneg). Extended immunophenotypic characterization of these MBL subtypes was performed, and significant differences in cell surface expression of CD23, CD49d, CD79b and FMC-7 were observed among the groups. Markers of risk in CLL such as CD38, ZAP70 and CD49d were infrequently expressed in CLL-like MBL, but were expressed in the majority of atypical MBL. Interphase cytogenetics was performed in 35 MBL cases, and del 13q14 was most common (22/30 CLL-like MBL cases). Gene expression analysis using oligonucleotide arrays was performed on seven CLL-like MBL, and showed activation of B-cell receptor associated pathways. Our findings underscore the diversity of MBL subtypes and further clarify the relationship between MBL and other lymphoproliferative disorders.

Original languageEnglish (US)
Pages (from-to)1459-1466
Number of pages8
Issue number9
StatePublished - Sep 2011

Bibliographical note

Funding Information:
MC Lanasa is supported by the Duke Clinical Oncology Research Clinical Development Program (K12) and is a fellow of the Leukemia and Lymphoma Society of America. This research is supported by the Leukemia and Lymphoma Society of America, the Harold Bernstein Family Fund, the VA Research Service and grants from the National Institutes of Health (NCI R03 CA128030, NCI R01 CA95241 and NCI U01 CA118444). We thank the study research subjects for their willingness to participate in this study and the hematology–oncology nurses and physician assistants for their special help. Flow Cytometry was performed in the Duke Human Vaccine Institute Flow Cytometry Core Facility that is supported by the National Institutes of Health award AI-51445.


  • B-cell immunology
  • Chronic lymphocytic leukemia
  • gene expression profiling
  • immunophenotype
  • monoclonal B lymphocytosis


Dive into the research topics of 'Immunophenotypic and gene expression analysis of monoclonal B-cell lymphocytosis shows biologic characteristics associated with good prognosis CLL'. Together they form a unique fingerprint.

Cite this